Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ankush Desai is active.

Publication


Featured researches published by Ankush Desai.


Annals of Internal Medicine | 2016

Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial

Mohammed K. Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A. Patel; Roopa Shivashankar; Vamadevan S. Ajay; A G Unnikrishnan; V. Usha Menon; Premlata Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Sahay; Muhammad Q. Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K.M. Venkat Narayan; Nikhil Tandon

BACKGROUND Achievement of diabetes care goals is suboptimal globally. Diabetes-focused quality improvement (QI) is effective but remains untested in South Asia. OBJECTIVE To compare the effect of a multicomponent QI strategy versus usual care on cardiometabolic profiles in patients with poorly controlled diabetes. DESIGN Parallel, open-label, pragmatic randomized, controlled trial. (ClinicalTrials.gov: NCT01212328). SETTING Diabetes clinics in India and Pakistan. PATIENTS 1146 patients (575 in the intervention group and 571 in the usual care group) with type 2 diabetes and poor cardiometabolic profiles (glycated hemoglobin [HbA1c] level ≥8% plus systolic blood pressure [BP] ≥140 mm Hg and/or low-density lipoprotein cholesterol [LDLc] level ≥130 mg/dL). INTERVENTION Multicomponent QI strategy comprising nonphysician care coordinators and decision-support electronic health records. MEASUREMENTS Proportions achieving HbA1c level less than 7% plus BP less than 130/80 mm Hg and/or LDLc level less than 100 mg/dL (primary outcome); mean risk factor reductions, health-related quality of life (HRQL), and treatment satisfaction (secondary outcomes). RESULTS Baseline characteristics were similar between groups. Median diabetes duration was 7.0 years; 6.8% and 39.4% of participants had preexisting cardiovascular and microvascular disease, respectively; mean HbA1c level was 9.9%; mean BP was 143.3/81.7 mm Hg; and mean LDLc level was 122.4 mg/dL. Over a median of 28 months, a greater percentage of intervention participants achieved the primary outcome (18.2% vs. 8.1%; relative risk, 2.24 [95% CI, 1.71 to 2.92]). Compared with usual care, intervention participants achieved larger reductions in HbA1c level (-0.50% [CI, -0.69% to -0.32%]), systolic BP (-4.04 mm Hg [CI, -5.85 to -2.22 mm Hg]), diastolic BP (-2.03 mm Hg [CI, -3.00 to -1.05 mm Hg]), and LDLc level (-7.86 mg/dL [CI, -10.90 to -4.81 mg/dL]) and reported higher HRQL and treatment satisfaction. LIMITATION Findings were confined to urban specialist diabetes clinics. CONCLUSION Multicomponent QI improves achievement of diabetes care goals, even in resource-challenged clinics. PRIMARY FUNDING SOURCE National Heart, Lung, and Blood Institute and UnitedHealth Group.


Journal of Pediatric Endocrinology and Metabolism | 2008

Gender Identity of Children and Young Adults with 5α-Reductase Deficiency

Edavan P. Praveen; Ankush Desai; Madan Lal Khurana; Jim Philip; Marumudi Eunice; Rajesh Khadgawat; Bindu Kulshreshtha; Kiran Kucheria; Devendra K. Gupta; Ashu Seith; Ariachery C. Ammini

Male pseudohermaphroditism (46,XY DSD) due to 5alpha-reductase deficiency has been recognized for the last few decades. There is scant literature on this entity in India. We compiled data on five patients with this disorder. Four of our five patients were reared as females. Our assessment of these children reveals that they had male gender identity from childhood. Three of the four reared as females chose to change gender role at adolescence, while the fourth is still prepubertal. We conclude that all these patients had male gender identity from early childhood. The parents took note of this only after the appearance of male secondary sexual characteristics at puberty, thereby giving an impression of change in gender identity and gender role.


Clinical Endocrinology | 2007

Reference range of thyroid hormones in normal Indian school‐age children

R. K. Marwaha; Nikhil Tandon; Ankush Desai; Ratnesh Kanwar; Khushi Grewal; Rashmi Aggarwal; Aparna Sastry; Satveer Singh; S. K. Ganguly; Kalaivani Mani

Objective  There is an ongoing debate on narrowing the TSH reference range in adults. In view of the scarce data on normal values of thyroid function tests in children from India, we planned to establish a reference range for thyroid hormones in school‐age children.


Diabetes Research and Clinical Practice | 2012

Improving diabetes care: Multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia—The CARRS Multi-center Translation Trial

Seema Shah; Kavita Singh; Mohammed K. Ali; Viswanathan Mohan; Muhammad Masood Kadir; Ambika Gopalakrishnan Unnikrishnan; Rakesh Sahay; Premlata Varthakavi; Mala Dharmalingam; Vijay Viswanathan; Qamar Masood; Ganapathi Bantwal; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Roopa Shivashankar; Vamadevan S. Ajay; K. Srinath Reddy; K.M. Venkat Narayan; Dorairaj Prabhakaran; Nikhil Tandon

AIMS Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in people with diabetes in South Asia. The CARRS Translation Trial tests the effectiveness, cost-effectiveness, and sustainability of a clinic-based multi-component CVD risk reduction intervention among people with diabetes in India and Pakistan. METHODS We randomly assigned 1146 adults with diabetes recruited from 10 urban clinic sites, to receive usual care by physicians or to receive an integrated multi-component CVD risk reduction intervention. The intervention involves electronic health record management, decision-support prompts to the healthcare team, and the support of a care coordinator to actively facilitate patient and provider adherence to evidence-based guidelines. The primary outcome is a composite of multiple CVD risk factor control (blood glucose and either blood pressure or cholesterol, or all three). Other outcomes include control of the individual CVD risk factors, process and patient-centered measures, cost-effectiveness, and acceptability/feasibility. CONCLUSION The CARRS Translation Trial tests a low-cost diabetes care delivery model in urban South Asia to achieve comprehensive cardio-metabolic disease case-management of high-risk patients (clinicaltrials.gov number: NCT01212328).


Clinical Endocrinology | 2012

The evolution of thyroid function with puberty

Raman K. Marwaha; Nikhil Tandon; Ankush Desai; Ratnesh Kanwar; Aparna Sastry; Archna Narang; Satveer Singh; Kuntal Bhadra; Kalavani Mani

Objective  This study was planned to describe thyroid functional status in different stages of puberty.


Indian Journal of Endocrinology and Metabolism | 2013

Assessment of iodine nutrition in pregnant north Indian subjects in three trimesters.

Emmy Grewal; Rajesh Khadgawat; Nandita Gupta; Ankush Desai; Nikhil Tandon

Objective: The cross-sectional study was carried out to assess the iodine status of pregnant women, using median urinary iodine concentration (MUI) as the measure of outcome, to document the impact of advancing gestation on the MUI in normal pregnancy. Materials and Methods: The present study assessed the MUI in casual urine samples from 50 pregnant subjects of each trimester and 50 age-matched non-pregnant controls. Results: The median (range) of urinary iodine concentration (UIC) in pregnant women was 304 (102-859) μg/L and only 2% of the subjects had prevalence of values under 150 μg/L (iodine insufficiency). With regard to the study cohort, median (range) UIC in the first, second, and third trimesters was 285 (102-457), 318 (102-805), and 304 (172-859) μg/L, respectively. Differences between the first, second, and third trimesters were not statistically significant. The MUI in the controls (305 μg/L) was not statistically different from the study cohort. Conclusion: The pregnant women had no iodine deficiency, rather had high median urinary iodine concentrations indicating more than adequate iodine intake. Larger community-based studies are required in iodine-sufficient populations, to establish gestation-appropriate reference ranges for UIC in pregnancy.


Clinical Endocrinology | 2012

Thyroid status two decades after salt iodization: country-wide data in school children from India.

Raman K. Marwaha; Nikhil Tandon; M.K. Garg; Ankush Desai; Ratnesh Kanwar; Aparna Sastry; Archna Narang; Saurav Arora; Kuntal Bhadra

Objective  Country‐wide evaluation of thyroid disorders in school children following two decades of universal salt iodization (USI) has not been carried out till date. This study was planned with aim to assess thyroid status of school children two decades after the launch of USI programme.


Fertility and Sterility | 2009

Reversible hypogonadism in Bardet-Biedl syndrome

Ankush Desai; Onkar Jha; Venkateswaran K. Iyer; Rima Dada; Rakesh Kumar; Nikhil Tandon

OBJECTIVE To report a patient with Bardet-Biedl syndrome (BBS) with known hypogonadotrophic hypogonadism who developed spontaneous reversal of hypogonadism in adulthood. DESIGN Case report and discussion. SETTING Endocrine unit of a tertiary hospital. PATIENT(S) A 30-year-old male patient with BBS. INTERVENTION(S) Clinical evaluation, fine-needle aspiration of the testes, hormonal, cytogenetic, and pathologic evaluation. MAIN OUTCOME MEASURE(S) Serum gonadotropins and testosterone levels and presence of spermatogenesis in testicular aspirate. RESULT(S) Serum testosterone and gonadotropin levels were within the normal adult male range. Testicular aspirates showed spermatogenic cells of all series, including numerous spermatozoa and a few intact seminiferous tubules. The overall picture appeared to be consistent with normal spermatogenesis. CONCLUSION(S) This is the first case of reversal of hypogonadotrophic hypogonadism in a male patient with BBS. Clinicians should look for such reversal in other patients with hypogonadotrophic hypogonadism and give appropriate prognosis.


Diabetic Medicine | 2017

Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort.

Yashdeep Gupta; D. Kapoor; Ankush Desai; Devarsetty Praveen; Rohina Joshi; R. Rozati; Neerja Bhatla; Dorairaj Prabhakaran; Prasuna Reddy; Anushka Patel; Nikhil Tandon

To investigate the distribution of and risk factors for dysglycaemia (Type 2 diabetes and prediabetes) in women with previous gestational diabetes mellitus in India.


European Journal of Endocrinology | 2016

Germline mutations and genotype–phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma

Reshma Pandit; Kranti Khadilkar; Vijaya Sarathi; Rajeev Kasaliwal; Manjunath Goroshi; Shruti Khare; Sandhya Nair; Vijaya Raghavan; Abhay N Dalvi; Priya Hira; Gwendolyn Fernandes; Pragati Aditya Sathe; Amey Rojekar; Gaurav Malhotra; Ganesh Bakshi; Gagan Prakash; Anil Bhansali; Rama Walia; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Ankush Desai; Nikhil M Bhagwat; Prashanth Mappa; Rajesh Rajput; Sudha Rao Chandrashekhar; Vyankatesh Shivane; Padma S. Menon; Anurag Lila; Tushar Bandgar; Nalini S. Shah

BACKGROUND Genetic aetiology of pheochromocytoma (PCC) and paraganglioma (PGL) is increasingly being studied; however, Asian Indian data on this aspect are scarce. OBJECTIVE To study the prevalence of germline mutations and genotype-phenotype correlation in Asian Indian PCC/PGL patients. DESIGN In this study, 150 index patients (M:F, 73:77) with PCC/PGL were evaluated. Phenotypic data were collected. Germline mutations in five susceptibility genes (RET, VHL, SDHB, SDHD and SDHC) were tested by sequencing and NF1 was diagnosed according to phenotype. RESULT Of the total population, 49 (32.7%) PCC/PGL patients had germline mutations (VHL: 23 (15.3%), RET: 13 (8.7%), SDHB: 9 (6%), SDHD: 2 (1.3%) and NF1: 2 (1.3%)). Amongst the 30 patients with familial and/or syndromic presentation, all had germline mutations (VHL: 14 (46.7%), RET: 13 (43.3%), SDHB: 1 (3.3%) and NF1: 2 (6.7%)). Out of 120 patients with apparently sporadic presentation, 19 (15.8%) had a germline mutation (VHL: 9 (7.5%), SDHB: 8 (6.7%) and SDHD: 2 (1.7%)). Mutation carriers were younger (29.9 ± 14.5 years vs 36.8 ± 14.9; P = 0.01) and had a higher prevalence of bilateral PCC (26.5% vs 2.9%, P < 0.001) and multifocal tumours (12.2% vs 0.96%, P = 0.06). Based on syndromic features, metastasis, location and number of tumours, around 96% mutations in our cohort could be detected by appropriately selected single gene testing. CONCLUSION Asian Indians with PCC/PGL differ from Western cohorts in having preponderance of VHL mutations in multifocal tumours and apparently sporadic unilateral PCC. Syndromic presentation, metastasis, location and number of PCC/PGL can be effectively used for guiding genetic prioritisation.

Collaboration


Dive into the Ankush Desai's collaboration.

Top Co-Authors

Avatar

Nikhil Tandon

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Rajesh Khadgawat

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Aparna Sastry

Defence Research and Development Organisation

View shared research outputs
Top Co-Authors

Avatar

Dorairaj Prabhakaran

Public Health Foundation of India

View shared research outputs
Top Co-Authors

Avatar

Kalaivani Mani

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Ratnesh Kanwar

Defence Research and Development Organisation

View shared research outputs
Top Co-Authors

Avatar

Archna Narang

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Bipin Sethi

St. John's Medical College

View shared research outputs
Top Co-Authors

Avatar

Kavita Singh

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Mala Dharmalingam

All India Institute of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge